Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 79

    Eli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpoint

    Eli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpoint

    Medical Dialogues Bureau19 Oct 2019 9:00 AM IST
    New Delhi: Eli Lilly and Company recently announced top-line results from its Phase 3 SEQUOIA trial evaluating pegilodecakin plus FOLFOX (folinic...
    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Medical Dialogues Bureau18 Oct 2019 1:50 PM IST
    Mumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited ("VRL") for the...
    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Medical Dialogues Bureau18 Oct 2019 1:40 PM IST
    MUMBAI -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA)...
    USFDA red flag to Torrent Pharmas Indrad facility

    USFDA red flag to Torrent Pharma's Indrad facility

    Medical Dialogues Bureau18 Oct 2019 1:15 PM IST
    New Delhi: The US health regulator has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP)...
    Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenza

    Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenza

    Medical Dialogues Bureau18 Oct 2019 12:28 PM IST
    US: Roche today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XofluzaTM...
    Tevas UK arm recalls some batches of Ranitidine: Medicines watchdog

    Teva's UK arm recalls some batches of Ranitidine: Medicines watchdog

    Medical Dialogues Bureau18 Oct 2019 9:14 AM IST
    Teva Pharmaceutical’s UK unit has recalled some batches of heartburn medicine Ranitidine, Britain’s medicines watchdog said on Thursday, making it the...
    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    Medical Dialogues Bureau17 Oct 2019 1:28 PM IST
    New Delhi: The US health regulator has red flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and...
    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Medical Dialogues Bureau17 Oct 2019 1:14 PM IST
    New Delhi: Sun Pharmaceutical Industries recently announced that one of its wholly-owned subsidiaries has launched Drizalma Sprinkle™ (duloxetine...
    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Medical Dialogues Bureau17 Oct 2019 12:19 PM IST
    "This is the first time in India when such large number of pharmacists have been penalised. We have also issued warnings to around 3,000 pharmacists...
    USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

    USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

    Farhat Nasim16 Oct 2019 6:20 PM IST
    Repeated failures at multiple sites of Torrent Pharma demonstrate that executive management oversight and control over the manufacture of drugs is...
    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Medical Dialogues Bureau16 Oct 2019 4:10 PM IST
    "We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
    JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

    JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

    Medical Dialogues Bureau16 Oct 2019 10:00 AM IST
    JnJ is facing more than 13,000 lawsuits tied to anti-psychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids,...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok